ORGO vs REG · rev $81.0M vs P/E 34, rev $1.45B
Organogenesis Holdings Inc (ORGO) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
ORGO currently screens at market cap $301.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ORGO and REG stock pages for the full models.
Not investment advice.